Labcorp to Announce Third Quarter 2026 Financial Results on October 28, 2026
Labcorp Holdings Inc LH
News
Diagnostic-Testing Stocks Slide After Proposed Cuts to Medicare Payments for Lab Services
Labcorp Highlights Strategic Priorities Driving Durable Growth and Shareholder Value at 2026 Investor Day
Moonwalk Biosciences Announces $70 Million Series B: NYSE Content Update
Labcorp Acquires MLM Medical Labs, Expanding Global Central Laboratory and Biomarker Capabilities for Clinical Trials
Labcorp Launches Next Generation of Labcorp Global Trial Connect™ to Help Sponsors and Investigator Sites Navigate Clinical Trial Complexity
Labcorp to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference
FDA Approves Alzheimer's Blood Test Developed by Roche and Eli Lilly
Labcorp to Offer First FDA-Cleared Blood Test to Detect Alzheimer's Disease Pathology in Both Primary and Specialty Care Settings
Labcorp and NACHC Launch Strategic Alliance to Strengthen Health Center Leadership and Advance Community Health
Labcorp to Host Investor Day on September 10, 2026
Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma
Labcorp Launches FDA-Approved PTEN Companion Diagnostic for Prostate Cancer
Labcorp Announces 2026 Second Quarter Results; Raises Full Year 2026 Guidance
Labcorp Launches Marker by Labcorp™ Genetic Health Panel, Expanding Consumer Access to Hereditary Genetic Risk Testing
Labcorp Declares Quarterly Dividend
The latest Oura and Fitbit wearables are smarter and sleeker than ever - but do they keep you healthy?
'Dr. Google' is done. AI chatbots like ChatGPT will change how we search for health information.
These charts show the stock market giving investors a lot to like - for now - as the S&P 500 nears 7,000
Labcorp to Launch Alzheimer's Blood Test in Primary-Care Settings
United States